From Science Week: Innovative arenas create collaboration for the city of the future

In a panel discussion during Science Week on February 1, it was discussed how innovative neutral arenas are central to the development of the smart and knowledge-intensive city.

Flemingsberg Science CEO Johnny Högberg participated together with a panel consisting of Sophia Sundberg, CEO, Barkaby Science, Peter Dobers, Professor of Business Administration with a focus on sustainable development and collaboration, Södertörn University, Johan Zachrisson, Business Development Manager, Fabege and Anton Västberg, Development Director, Region Stockholm. All under the guidance of moderator Lydia Capolicchio.

Watch on Youtube.

Published On: 2 February 2023

  • Hela wins Flemingsberg Science Award

    Hela is a company that is developing a mobile application that helps people with heart conditions improve their cardiac rehabilitation. The app encourages daily exercise, provides care support, and the ability to monitor progress.

  • Ten-year-old XNK Therapeutics experiences rapid growing with own GMP facility

    XNK Therapeutics has expanded significantly in the past year and now has access to its own GMP-standard production lab.

  • Restart for Tullinge work hub

    Just before the pandemic, a research project was initiated in Tullinge in which residents were offered a place at a local work hub as an alternative to commuting to work. The hub is now seeing something of a reopening in a project aimed at increasing shared use and resource efficiency.

  • Vesna ready for the next step in the service of residents

    Vesna Jovic is now leaving her role as municipality director for Huddinge – after 28 years at the authority. Her next position is CEO for the Swedish Association of Local Authorities and Regions, SKL. As she leaves Huddinge, she can look back on the burgeoning development of Flemingsberg and Huddinge.

  • Curiosity took him from the lab to the stock market

    Mathias Svahn is a CEO who still collects the mail and makes the coffee, even as he ranks among the highflyers leading the development of drugs of the future. Curiosity has taken him from the lab to the helm of a listed company. And it all started with a pregnancy.